Citadel Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Citadel Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$34K	–	13261
2025 Q1	$34K	Buy	+200	New	+$34.7K	﹤0.01%	12696
2023 Q4	–	Sell	-200	Closed	-$29.3K	–	14559
2023 Q3	$29.3K	Buy	+200	New	+$30.5K	﹤0.01%	12286
2023 Q2	–	Sell	-2,000	Closed	-$310K	–	14578
2023 Q1	$310K	Buy	+2,000	New	+$314K	﹤0.01%	9312
2022 Q1	–	Sell	-2,300	Closed	-$373K	–	13877
2021 Q4	$373K	Buy	+2,300	New	+$372K	﹤0.01%	10412
2021 Q2	–	Sell	-6,400	Closed	-$1.03M	–	13877
2021 Q1	$1.03M	Buy	+6,400	New	+$1.1M	﹤0.01%	8038
2020 Q1	–	Sell	-2,300	Closed	-$342K	–	9749
2019 Q4	$342K	Buy	2,300 +600	+35%	+$82.4K	﹤0.01%	7389
2019 Q3	$210K	Sell	1,700 -1,200	-41%	-$160K	﹤0.01%	8091
2019 Q2	$408K	Sell	2,900 -2,300	-44%	-$317K	﹤0.01%	7116
2019 Q1	$784K	Buy	+5,200	New	+$748K	﹤0.01%	6021
2018 Q4	–	Sell	-2,100	Closed	-$333K	–	9291
2018 Q3	$333K	Sell	2,100 -1,600	-43%	-$242K	﹤0.01%	7398
2018 Q2	$518K	Sell	3,700 -1,900	-34%	-$261K	﹤0.01%	6302
2018 Q1	$744K	Buy	+5,600	New	+$765K	﹤0.01%	5245
2017 Q3	–	Sell	-6,000	Closed	-$684K	–	7658
2017 Q2	$684K	Buy	+6,000	New	+$645K	﹤0.01%	4664
2017 Q1	–	Sell	-6,500	Closed	-$591K	–	7605
2016 Q4	$591K	Sell	6,500 -2,400	-27%	-$225K	﹤0.01%	4643
2016 Q3	$887K	Buy	+8,900	New	+$873K	﹤0.01%	3998

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Citadel Advisors's FBT Position: Q2 2026 in Review

Citadel Advisors opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 5,364 shares worth $1.33M. The stake represents ﹤0.01% of the portfolio and ranks #7504 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in FBT as recently as Q3 2025.

Citadel Advisors first reported a position in FBT in Q4 2014 and has held it in 41 quarters since. The position peaked at $9.4M in Q3 2015. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Citadel Advisors held 5,364 shares of First Trust NYSE Arca Biotechnology Index Fund worth $1.33M as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new Citadel Advisors position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7504 holding.
Citadel Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2014 and has held it in 41 quarters since.
Citadel Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.4M in Q3 2015.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.